// App-Quantinova.ai

1584 : Analytical and clinical validation of the Epic Circulating Tumor Cell (CTC) Platform: enrichment-free CTC detection and biomarker characterization

Researchers

Presenter

  • Ryon P. Graf

Principal Investigators

  • David T. Valenta

  • Mark Landers

  • Bryan Taggart

  • Stephanie Greene

  • Shannon L. Werner

  • Ryan Dittamore

  • Dena Marrinucci

Medical Centers

  • Epic Sciences, Inc., San Diego, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Androgen receptor

  • Circulating tumor cells

  • Cluster of differentiation 45

  • ETS transcription factor ERG

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved